NCT07502560: A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland
- State
- Under way
- Phase
- Phase 4
- People
- 33,609 planned
- Started
- 31 Mar 2026
- Primary completion
- 1 Apr 2030
- Arms
- Recombinant zoster vaccine Group
- Results
- None posted
- 31 Mar 2026: Trial registered
- 31 Mar 2026: Trial started